Please ensure Javascript is enabled for purposes of website accessibility


Aug 20, 2018

Viela Bio begins clinical trials months after $250M spinoff

One of Maryland’s best-funded biotech companies took a milestone first step Monday, announcing it has begun clinical trials of a medication it is developing. Gaithersburg-based Viela Bio was spun out of MedImmune, a subsidiary of AstraZeneca, last month with $250 million in financing and a promise of creating 100 jobs within five years. Monday’s announcement is a […]

Feb 28, 2018

With $250M from investors, Viela Bio out on its own

MedImmune spun out Viela Bio as an independent biotechnology company with $250 million in Series A financing and six potential medicines, the companies announced Wednesday. Viela Bio will be based in Gaithersburg and will focus on inflammation and autoimmunity biologics, targeting pathways that are the root of disease. The company said it plans to create […]

Mar 2, 2016

JHU to offer new Ph.D program with biomedical firm

Johns Hopkins University is launching a new Ph.D program that will offer students hands-on work experience in the biopharmaceutical field, where they’ll learn about the process of discovering and developing new drugs. Officials say the partnership between the university and MedImmune, a company that focuses on biologics – prescription medicines developed from biological sources – […]

Sep 18, 2015

Frederick approves MedImmune expansion, road improvements

FREDERICK — The city of Frederick has finalized a loan package that will approve expansion of MedImmune’s Frederick biotech manufacturing plant and improve roads around the business. The Frederick News-Post reports that the Board of Aldermen voted Thursday to approve a series of agreements between the company, the city and the State Highway Administration to […]

Sep 16, 2015

Plant’s expansion to continue with Md. county’s support

FREDERICK — The Frederick County Council has voted to financially support the expansion of MedImmune’s Frederick manufacturing plant, a project the company says will bring 300 new jobs. The Frederick News-Post reports that, in a 6-1 vote, the County Council on Tuesday approved the county’s $3.8 million contribution to a $6.8 million conditional loan for […]

Nov 12, 2014

MedImmune certified for energy program

Gaithersburg-based MedImmune, the biologics research and development arm of AstraZeneca, has been certified by the Department of Energy’s Superior Energy Performance program for improvements at its headquarters facility. MedImmune is the first company in Maryland  to achieve the certification, the firm said. Under its management program, MedImmune improved energy performance by 8.54 percent in [...]

Apr 29, 2014

MedImmune expands partnership with USM

Gaithersburg-based MedImmune is expanding its recently announced research partnership with the University of Maryland, Baltimore to include two more UM campuses: College Park and Baltimore County.

Feb 12, 2014

MedImmune inks deal

Gaithersburg-based MedImmune has entered into a three-year partnership with the Clinical and Translational Science Institute at the University of California, San Francisco.

Sep 25, 2013

UMB, MedImmune agree to collaborate

The University of Maryland, Baltimore and MedImmune Inc., of Gaithersburg, a subsidiary of British drug maker AstraZeneca PLC, announced they have entered into a five-year, $6 million agreement to work on novel bioscience research in Maryland.

Mar 18, 2013

AstraZeneca reorganization to cut 1,600 jobs, move 300 to Gaithersburg

TRENTON, N.J. — Struggling Anglo-Swedish drugmaker AstraZeneca PLC said Monday that it will eliminate 1,600 jobs, mostly in the U.S. and United Kingdom, as its new CEO starts a major research and development reorganization. The cuts, meant to reduce costs and make research programs more productive, come just weeks after the company reported big drops […]

Apr 27, 2012

Jallal named to UM Health Sciences Research Park board

Bahija Jallal, Ph.D., executive vice president of research and development at MedImmune, has been named to the board of directors of the UM Health Sciences Research Park Corp. Jallal is a member of MedImmune’s executive team and of the research and development leadership team of parent company AstraZeneca. She oversees research, development, regulatory and clinical […]

Nov 15, 2011

O’Malley to bring more than 100 on trade mission to India

Gov. Martin O’Malley will embark on a trade mission to India, the first by a sitting Maryland governor, at the end of November with a delegation of more than 100 educators, business executives and elected officials, his office announced Tuesday. The trip will stretch from Nov. 28 to Dec. 4 and include a short stop […]

Networking Calendar

Submit an entry for the business calendar